https://www.marketscreener.com/quote/stock/MOMENTA-PHARMACEUTICALS-I-10057/news/Momenta-Pharmaceuticals-Announces-Fast-Track-Designation-for-M281-in-Hemolytic-Disease-of-the-Fetus-34215241/?utm_source=telegram&utm_medium=social&utm_campaign=share